Soleus Capital Management »

Apogee Therapeutics shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $978k 35k 27.94
2023-09-30 $746k 35k 21.30